Program :
Metabolism, hematopoietic development and splicing
Wednesday 10/10/2012
5.30 p.m. welcoming of participants
7 p.m. meal
8:45 p.m. - 9:30 p.m. Session 1
Moderator: Michèle SOUYRI
8:30 p.m. - 8:45 p.m. Congress opening:
Françoise PORTEU (CHO deputy president)
8:45 p.m. - 9:30 p.m. Georges Lacaud
“Cellular and molecular mechanisms of development of the hematopoietic system”
Paterson Institute for Cancer Research, The University of Manchester, Wilmslow Road, Manchester, M20 4BX, United Kingdom
Thursday 11/10/2012, 9 a.m. - 12 p.m. Session 2
Moderators: Estelle DUPREZ / Eric SOLER
9 a.m. - 9:45 a.m. Hinrich Gronemeyer
“Global analysis of signaling pathways and quality control solutions.”
Institute of genetics and molecular and cellular biology of genetics and molecular and cellular biology. Igbmc - 1 rue Laurent Fries / BP 10142/67404 Illkirch CEDEX
9.45 a.m. - 10 a.m. (summary 1): Concern
10h - 10h15 (summary 2): Garrick
10:15 am - 10:45 am Break
10.45 am - 11 am (summary 3): Guide
11h - 11h15 (summary 4): Vincent-Fabert
11.15 a.m. - 12 p.m. Denis Thieffry
“Logical modeling of haematopoietic cell specification and reprogramming”
Institute of Biology of the Ecole Normale Supérieure (IBENS),
UMR CNRS 8197 - INSERM 1024, 46 rue d'Ulm, 75005 Paris, France
Thursday 11/10/2012, 4 p.m. - 7.15 p.m. Session 3
Moderators: Sandrine SARRAZIN / Cyril BROCCARDO
4 p.m. - 4.45 p.m. Ludovic Vallier
“Human Induced Pluripotent Stem Cells: New opportunities and old challenges.”
University of Cambridge- Department of Surgery -Laboratory for Regenerative Medicine-West Forvie Building, Robinson Way- Cambridge CB2 0SZ- United Kingdom
4.45 p.m. - 5 p.m. (summary 5): Saliba
5 p.m. - 5.15 p.m. (summary 6): Petit-cocault
5.15 p.m. - 5.45 p.m. Break
5.45 p.m. - 6 p.m. (summary 7): Juban
6 p.m. - 6.45 p.m. Ivan Moura
“New roles of Transferrin Receptor in physiology and disease.”
INSERM U699- Renal immunopathology, receptors and inflammation, Laboratory of Excellence in Red Globules (GR-ex) and Institut Hospitalo-Universitaire (IHU) Imagine Foundation. Paris, France.
Thursday 11/10/2012, 6.45pm General Assembly
Thursday 10/11/2012, 8 p.m. Gala meal
Friday 12/10/2012, 9 a.m. - 12:15 p.m. Session 4
Moderators: Françoise PFLUMIO / Eric DELABESSE
9–9.45 am Jérome Tamburini
“Deregulation of translation in acute myeloid leukemia: therapeutic implications. ”
Cochin Institute, Paris Descartes University, CNRS UMR8104, Inserm U1016, Paris.
9.45 a.m. - 10 a.m. (summary 8): Mercher
10h - 10h15 (summary 9): Levescot
10.15–10.30 am (summary 10): From Laval
10.30 a.m. - 11 a.m. Break
11h - 11h15 (summary 11): Poglio
11.15 - 11.30 a.m. (summary 12): Zhang
11:30 am - 12:15 pm Olivier Herault
“Gpx3 (glutathione peroxidase-3) is involved in the activity of normal and leukemic stem cells”
François-Rabelais University of Tours, 3 rue des Tanneurs, BP 4103, 7041 TOURS Cedex01
Friday 12/10/2012, 3 p.m. - 6 p.m. Session 5
Moderators: Françoise PORTEU / Frédéric MAZURIER
3 p.m. - 3:45 p.m. Nathalie Mazure
“Hypoxia / HIF and glycolysis in cancer”
Institute of Developmental Biology and Cancer Research, University of Nice, CNRS-UMR 6543, Center Antoine Lacassagne, 33 Avenue de Valombrose, 06189 Nice, France.
3:45 p.m. - 4 p.m. (summary 13): Rouault Pierre
4 p.m. - 4:15 p.m. (summary 14): Scotland
4.15 p.m. - 4.45 p.m. Break
4.45 p.m. - 5 p.m. (summary 15): Mylonas
5 p.m. - 5.15 p.m. (summary 16): Hilpert
5.15 p.m. - 6 p.m. Kamil Kranc
“The role of hypoxia signaling pathways in normal and leukaemic Haematopoiesis”
Paul O'Gorman Leukaemia Research Center, Institute of Cancer Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, United Kingdom
6 - 8 p.m. Poster session
Saturday 10/13/2012, 8:30 am - 11:15 am. Session 6
Moderators: Michèle GOODHARDT / Christel GUILLOUF
8:30 am - 9:15 am Didier Auboeuf
“Splicing programs and cancer”
Cancer Research Center (CRCL), 28 rue Laennec, 69008 Lyon.
9:15 a.m. - 9:30 a.m. (summary 17): Rousselet
9.30 a.m. - 9.45 a.m. (summary 18): Renou
9.45 a.m. - 10.15 a.m. Break
10.15 - 10.30 a.m. (summary 19): Parcelier
10.30 a.m. - 11.15 a.m. Christian Muchardt
“Silencing factors and their impact on alternative splicing”
Institut Pasteur, 25-28 rue du Docteur Roux, 75015 PARIS, France.
Prix QuickFirePoster
Jimena Castorena
UMRS-MD1197 INSERM "SToRM" Hopital Paul Brousse, Villejuif, Universite Paris Saclay, INSERM, Paris Saclay
Léa Pierre,
CEA, Thérapies et réponse immunitaire dans les cancers (CTM UMR 1231)
UFR de Santé, Dijon (Université de Bourgogne), Université de Bourgogne - UFR SVTE, Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon]
Cecilia Marin Oyarzun
Inserm UMR1287, Inserm, Gustave Roussy, Université Paris Saclay
Prix
du
public
Prix Poster
Guillaume Goncalves
Tumor Biomechanics Lab, CRBS, Strasbourg, INSERM U1109
Romain Pfeifer
Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique
Giovanna Dainese
Laboratoire de Biologie du Développement [IBPS], Sorbonne Université, Centre National de la Recherche Scientifique, Institut de Biologie Paris Seine, Sorbonne Université, CNRS UMR7622, INSERM U1156, Institut de Biologie Paris Seine (IBPS), Developmental Biology Unit, 75005 Paris, France.
Prix communication orale
Jasmin Rettkowski
Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Maria Kalogeraki
Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.
Laura Anselmi
Gustave Roussy, INSERM U1170, Université Paris-Saclay, PEDIAC program
Inserm U1170, Gustave Roussy, Université Paris-Saclay